1. Home
  2. ACCO vs EVMN Comparison

ACCO vs EVMN Comparison

Compare ACCO & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acco Brands Corporation

ACCO

Acco Brands Corporation

HOLD

Current Price

$4.22

Market Cap

353.3M

ML Signal

HOLD

Logo Evommune Inc.

EVMN

Evommune Inc.

HOLD

Current Price

$11.22

Market Cap

405.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACCO
EVMN
Founded
1893
2020
Country
United States
United States
Employees
N/A
48
Industry
Publishing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
353.3M
405.2M
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
ACCO
EVMN
Price
$4.22
$11.22
Analyst Decision
Buy
Strong Buy
Analyst Count
1
10
Target Price
$5.00
$43.88
AVG Volume (30 Days)
608.8K
739.9K
Earning Date
04-30-2026
06-11-2026
Dividend Yield
9.26%
N/A
EPS Growth
141.51
N/A
EPS
0.20
N/A
Revenue
$1,524,700,000.00
N/A
Revenue This Year
$3.10
N/A
Revenue Next Year
$0.89
N/A
P/E Ratio
$21.15
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.81
$10.47
52 Week High
$4.39
$33.20

Technical Indicators

Market Signals
Indicator
ACCO
EVMN
Relative Strength Index (RSI) 57.81 32.97
Support Level $3.73 $10.47
Resistance Level $4.36 $21.21
Average True Range (ATR) 0.14 0.80
MACD 0.02 0.25
Stochastic Oscillator 73.00 25.92

Price Performance

Historical Comparison
ACCO
EVMN

About ACCO Acco Brands Corporation

ACCO Brands Corp is a consumer, technology and business branded products company providing brands and product solutions used in schools, homes and at work. Its brands include At-A-Glance, Barrilito, Buro, Esselte, Five Star, Foroni, GBC, Hilroy, Kensington, Leitz, Mead, PowerA, Quartet, Rapid, Swingline and Tilibra. The Company's product categories include gaming and computer accessories, storage and organization, notebooks, shredding, laminating and binding machines, dry erase boards and do-it-yourself tools. The Company operates through two segments, Americas and International. Americas includes the U.S., Canada, Brazil, Mexico and Chile, and International includes EMEA, Australia, New Zealand and Asia. Its products are sold in the U.S., Europe, Australia, Canada, Brazil and Mexico.

About EVMN Evommune Inc.

Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.

Share on Social Networks: